nodes	percent_of_prediction	percent_of_DWPC	metapath
Mometasone—CYP2C8—Vismodegib—skin cancer	0.416	0.738	CbGbCtD
Mometasone—CYP2C8—Fluorouracil—skin cancer	0.148	0.262	CbGbCtD
Mometasone—Hyperadrenocorticism—Temozolomide—skin cancer	0.0153	0.0359	CcSEcCtD
Mometasone—Nasal irritation—Fluorouracil—skin cancer	0.0126	0.0295	CcSEcCtD
Mometasone—Leukoderma—Imiquimod—skin cancer	0.0093	0.0218	CcSEcCtD
Mometasone—Telangiectasia—Fluorouracil—skin cancer	0.00927	0.0217	CcSEcCtD
Mometasone—Skin striae—Bleomycin—skin cancer	0.00883	0.0207	CcSEcCtD
Mometasone—Bacterial infection—Imiquimod—skin cancer	0.00857	0.0201	CcSEcCtD
Mometasone—Fluocinonide—SMO—skin cancer	0.00814	0.837	CrCbGaD
Mometasone—Nasal discomfort—Fluorouracil—skin cancer	0.00764	0.0179	CcSEcCtD
Mometasone—Musculoskeletal pain—Vismodegib—skin cancer	0.0076	0.0178	CcSEcCtD
Mometasone—Folliculitis—Vemurafenib—skin cancer	0.00738	0.0173	CcSEcCtD
Mometasone—Folliculitis—Imiquimod—skin cancer	0.00629	0.0147	CcSEcCtD
Mometasone—Allergic contact dermatitis—Fluorouracil—skin cancer	0.00625	0.0146	CcSEcCtD
Mometasone—Trauma—Bleomycin—skin cancer	0.0059	0.0138	CcSEcCtD
Mometasone—Influenza-like symptoms—Imiquimod—skin cancer	0.00554	0.013	CcSEcCtD
Mometasone—Otitis media—Imiquimod—skin cancer	0.00508	0.0119	CcSEcCtD
Mometasone—Tingling sensation—Imiquimod—skin cancer	0.00492	0.0115	CcSEcCtD
Mometasone—Stinging—Imiquimod—skin cancer	0.00488	0.0114	CcSEcCtD
Mometasone—Musculoskeletal pain—Vemurafenib—skin cancer	0.00469	0.011	CcSEcCtD
Mometasone—Viral infection—Imiquimod—skin cancer	0.00438	0.0103	CcSEcCtD
Mometasone—Ulcer—Imiquimod—skin cancer	0.00418	0.0098	CcSEcCtD
Mometasone—Folliculitis—Dactinomycin—skin cancer	0.00417	0.00977	CcSEcCtD
Mometasone—Influenza like illness—Imiquimod—skin cancer	0.00384	0.009	CcSEcCtD
Mometasone—Oral candidiasis—Temozolomide—skin cancer	0.00373	0.00874	CcSEcCtD
Mometasone—Influenza-like symptoms—Temozolomide—skin cancer	0.00332	0.00777	CcSEcCtD
Mometasone—Back pain—Vismodegib—skin cancer	0.00317	0.00744	CcSEcCtD
Mometasone—Nasal congestion—Imiquimod—skin cancer	0.00315	0.00738	CcSEcCtD
Mometasone—Injury—Imiquimod—skin cancer	0.00312	0.00732	CcSEcCtD
Mometasone—Otitis media—Temozolomide—skin cancer	0.00304	0.00713	CcSEcCtD
Mometasone—Ulcer—Bleomycin—skin cancer	0.00297	0.00696	CcSEcCtD
Mometasone—Endocrine disorder—Temozolomide—skin cancer	0.00286	0.0067	CcSEcCtD
Mometasone—Arthralgia—Vismodegib—skin cancer	0.00279	0.00654	CcSEcCtD
Mometasone—Myalgia—Vismodegib—skin cancer	0.00279	0.00654	CcSEcCtD
Mometasone—Ulcer—Dactinomycin—skin cancer	0.00277	0.00649	CcSEcCtD
Mometasone—Wheezing—Bleomycin—skin cancer	0.00273	0.00639	CcSEcCtD
Mometasone—Tingling sensation—Fluorouracil—skin cancer	0.00272	0.00636	CcSEcCtD
Mometasone—Stinging—Fluorouracil—skin cancer	0.0027	0.00631	CcSEcCtD
Mometasone—Viral infection—Temozolomide—skin cancer	0.00262	0.00615	CcSEcCtD
Mometasone—Influenza—Imiquimod—skin cancer	0.00248	0.00581	CcSEcCtD
Mometasone—Oral candidiasis—Docetaxel—skin cancer	0.00248	0.00581	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Vismodegib—skin cancer	0.00244	0.00572	CcSEcCtD
Mometasone—Musculoskeletal pain—Temozolomide—skin cancer	0.0024	0.00562	CcSEcCtD
Mometasone—Bronchitis—Imiquimod—skin cancer	0.00239	0.00559	CcSEcCtD
Mometasone—Dyspepsia—Vismodegib—skin cancer	0.00236	0.00552	CcSEcCtD
Mometasone—Decreased appetite—Vismodegib—skin cancer	0.00233	0.00545	CcSEcCtD
Mometasone—Fatigue—Vismodegib—skin cancer	0.00231	0.00541	CcSEcCtD
Mometasone—Ulcer—Fluorouracil—skin cancer	0.00231	0.00541	CcSEcCtD
Mometasone—Upper respiratory tract infection—Imiquimod—skin cancer	0.00231	0.0054	CcSEcCtD
Mometasone—Influenza like illness—Temozolomide—skin cancer	0.0023	0.00539	CcSEcCtD
Mometasone—Pain—Vismodegib—skin cancer	0.00229	0.00537	CcSEcCtD
Mometasone—Candida infection—Temozolomide—skin cancer	0.00226	0.0053	CcSEcCtD
Mometasone—Injury—Bleomycin—skin cancer	0.00222	0.0052	CcSEcCtD
Mometasone—Gastrointestinal pain—Vismodegib—skin cancer	0.00219	0.00513	CcSEcCtD
Mometasone—Dermatitis contact—Fluorouracil—skin cancer	0.00216	0.00506	CcSEcCtD
Mometasone—Conjunctivitis—Imiquimod—skin cancer	0.00215	0.00504	CcSEcCtD
Mometasone—Urinary tract infection—Imiquimod—skin cancer	0.00215	0.00504	CcSEcCtD
Mometasone—Abdominal pain—Vismodegib—skin cancer	0.00212	0.00496	CcSEcCtD
Mometasone—Mediastinal disorder—Vemurafenib—skin cancer	0.0021	0.00492	CcSEcCtD
Mometasone—Sinusitis—Imiquimod—skin cancer	0.00208	0.00486	CcSEcCtD
Mometasone—Otitis media—Docetaxel—skin cancer	0.00202	0.00474	CcSEcCtD
Mometasone—Ear pain—Temozolomide—skin cancer	0.00202	0.00472	CcSEcCtD
Mometasone—Rhinitis—Imiquimod—skin cancer	0.00199	0.00466	CcSEcCtD
Mometasone—Pharyngitis—Imiquimod—skin cancer	0.00197	0.00462	CcSEcCtD
Mometasone—Back pain—Vemurafenib—skin cancer	0.00196	0.00459	CcSEcCtD
Mometasone—Gastroenteritis—Temozolomide—skin cancer	0.00194	0.00455	CcSEcCtD
Mometasone—Asthenia—Vismodegib—skin cancer	0.00192	0.0045	CcSEcCtD
Mometasone—Pruritus—Vismodegib—skin cancer	0.00189	0.00444	CcSEcCtD
Mometasone—Nasal congestion—Temozolomide—skin cancer	0.00189	0.00442	CcSEcCtD
Mometasone—Diarrhoea—Vismodegib—skin cancer	0.00183	0.00429	CcSEcCtD
Mometasone—Immune system disorder—Imiquimod—skin cancer	0.00179	0.0042	CcSEcCtD
Mometasone—Mediastinal disorder—Imiquimod—skin cancer	0.00179	0.00419	CcSEcCtD
Mometasone—Cough—Vemurafenib—skin cancer	0.00177	0.00414	CcSEcCtD
Mometasone—Bronchospasm—Bleomycin—skin cancer	0.00173	0.00406	CcSEcCtD
Mometasone—Myalgia—Vemurafenib—skin cancer	0.00173	0.00404	CcSEcCtD
Mometasone—Arthralgia—Vemurafenib—skin cancer	0.00173	0.00404	CcSEcCtD
Mometasone—Vomiting—Vismodegib—skin cancer	0.0017	0.00399	CcSEcCtD
Mometasone—Rash—Vismodegib—skin cancer	0.00169	0.00396	CcSEcCtD
Mometasone—Dermatitis—Vismodegib—skin cancer	0.00169	0.00395	CcSEcCtD
Mometasone—Back pain—Imiquimod—skin cancer	0.00167	0.00392	CcSEcCtD
Mometasone—Anaphylactic shock—Vemurafenib—skin cancer	0.00165	0.00388	CcSEcCtD
Mometasone—Infection—Vemurafenib—skin cancer	0.00164	0.00385	CcSEcCtD
Mometasone—Nausea—Vismodegib—skin cancer	0.00159	0.00373	CcSEcCtD
Mometasone—Angioedema—Imiquimod—skin cancer	0.00158	0.0037	CcSEcCtD
Mometasone—Influenza like illness—Docetaxel—skin cancer	0.00153	0.00359	CcSEcCtD
Mometasone—Cough—Imiquimod—skin cancer	0.00151	0.00353	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00151	0.00353	CcSEcCtD
Mometasone—Candida infection—Docetaxel—skin cancer	0.0015	0.00353	CcSEcCtD
Mometasone—Chest pain—Imiquimod—skin cancer	0.00147	0.00345	CcSEcCtD
Mometasone—Myalgia—Imiquimod—skin cancer	0.00147	0.00345	CcSEcCtD
Mometasone—Arthralgia—Imiquimod—skin cancer	0.00147	0.00345	CcSEcCtD
Mometasone—Dry mouth—Imiquimod—skin cancer	0.00144	0.00337	CcSEcCtD
Mometasone—Decreased appetite—Vemurafenib—skin cancer	0.00144	0.00337	CcSEcCtD
Mometasone—Bronchitis—Temozolomide—skin cancer	0.00143	0.00335	CcSEcCtD
Mometasone—Fatigue—Vemurafenib—skin cancer	0.00143	0.00334	CcSEcCtD
Mometasone—Nasopharyngitis—Fluorouracil—skin cancer	0.00142	0.00332	CcSEcCtD
Mometasone—Infection—Imiquimod—skin cancer	0.0014	0.00328	CcSEcCtD
Mometasone—Upper respiratory tract infection—Temozolomide—skin cancer	0.00138	0.00324	CcSEcCtD
Mometasone—Anorexia—Imiquimod—skin cancer	0.00134	0.00315	CcSEcCtD
Mometasone—Body temperature increased—Vemurafenib—skin cancer	0.00131	0.00306	CcSEcCtD
Mometasone—Pharyngitis—Dactinomycin—skin cancer	0.00131	0.00306	CcSEcCtD
Mometasone—Urinary tract infection—Temozolomide—skin cancer	0.00129	0.00302	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00129	0.00301	CcSEcCtD
Mometasone—Upper respiratory tract infection—Fluorouracil—skin cancer	0.00127	0.00298	CcSEcCtD
Mometasone—Paraesthesia—Imiquimod—skin cancer	0.00127	0.00297	CcSEcCtD
Mometasone—Dyspnoea—Imiquimod—skin cancer	0.00126	0.00295	CcSEcCtD
Mometasone—Sinusitis—Temozolomide—skin cancer	0.00124	0.00291	CcSEcCtD
Mometasone—Dyspepsia—Imiquimod—skin cancer	0.00124	0.00291	CcSEcCtD
Mometasone—Decreased appetite—Imiquimod—skin cancer	0.00123	0.00287	CcSEcCtD
Mometasone—Fatigue—Imiquimod—skin cancer	0.00122	0.00285	CcSEcCtD
Mometasone—Pain—Imiquimod—skin cancer	0.00121	0.00283	CcSEcCtD
Mometasone—Urinary tract infection—Fluorouracil—skin cancer	0.00119	0.00278	CcSEcCtD
Mometasone—Conjunctivitis—Fluorouracil—skin cancer	0.00119	0.00278	CcSEcCtD
Mometasone—Asthenia—Vemurafenib—skin cancer	0.00119	0.00278	CcSEcCtD
Mometasone—Pharyngitis—Temozolomide—skin cancer	0.00118	0.00277	CcSEcCtD
Mometasone—Pruritus—Vemurafenib—skin cancer	0.00117	0.00274	CcSEcCtD
Mometasone—Gastrointestinal pain—Imiquimod—skin cancer	0.00115	0.0027	CcSEcCtD
Mometasone—Epistaxis—Fluorouracil—skin cancer	0.00115	0.0027	CcSEcCtD
Mometasone—Sinusitis—Fluorouracil—skin cancer	0.00115	0.00268	CcSEcCtD
Mometasone—Diarrhoea—Vemurafenib—skin cancer	0.00113	0.00265	CcSEcCtD
Mometasone—Abdominal pain—Imiquimod—skin cancer	0.00112	0.00261	CcSEcCtD
Mometasone—Body temperature increased—Imiquimod—skin cancer	0.00112	0.00261	CcSEcCtD
Mometasone—Rhinitis—Fluorouracil—skin cancer	0.0011	0.00258	CcSEcCtD
Mometasone—Pharyngitis—Fluorouracil—skin cancer	0.00109	0.00255	CcSEcCtD
Mometasone—Immune system disorder—Temozolomide—skin cancer	0.00107	0.00252	CcSEcCtD
Mometasone—Mediastinal disorder—Temozolomide—skin cancer	0.00107	0.00251	CcSEcCtD
Mometasone—Cough—Bleomycin—skin cancer	0.00107	0.00251	CcSEcCtD
Mometasone—Vomiting—Vemurafenib—skin cancer	0.00105	0.00246	CcSEcCtD
Mometasone—Chest pain—Bleomycin—skin cancer	0.00105	0.00245	CcSEcCtD
Mometasone—Myalgia—Bleomycin—skin cancer	0.00105	0.00245	CcSEcCtD
Mometasone—Rash—Vemurafenib—skin cancer	0.00104	0.00244	CcSEcCtD
Mometasone—Dermatitis—Vemurafenib—skin cancer	0.00104	0.00244	CcSEcCtD
Mometasone—Headache—Vemurafenib—skin cancer	0.00104	0.00243	CcSEcCtD
Mometasone—Nasopharyngitis—Docetaxel—skin cancer	0.00102	0.0024	CcSEcCtD
Mometasone—Asthenia—Imiquimod—skin cancer	0.00101	0.00237	CcSEcCtD
Mometasone—Anaphylactic shock—Bleomycin—skin cancer	0.001	0.00235	CcSEcCtD
Mometasone—Back pain—Temozolomide—skin cancer	0.001	0.00235	CcSEcCtD
Mometasone—Pruritus—Imiquimod—skin cancer	0.000998	0.00234	CcSEcCtD
Mometasone—Infection—Bleomycin—skin cancer	0.000996	0.00233	CcSEcCtD
Mometasone—Nausea—Vemurafenib—skin cancer	0.000983	0.0023	CcSEcCtD
Mometasone—Myalgia—Dactinomycin—skin cancer	0.000975	0.00228	CcSEcCtD
Mometasone—Bronchospasm—Docetaxel—skin cancer	0.000973	0.00228	CcSEcCtD
Mometasone—Diarrhoea—Imiquimod—skin cancer	0.000965	0.00226	CcSEcCtD
Mometasone—Anorexia—Bleomycin—skin cancer	0.000955	0.00224	CcSEcCtD
Mometasone—Angioedema—Temozolomide—skin cancer	0.000947	0.00222	CcSEcCtD
Mometasone—Infection—Dactinomycin—skin cancer	0.000929	0.00218	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000913	0.00214	CcSEcCtD
Mometasone—Cough—Temozolomide—skin cancer	0.000904	0.00212	CcSEcCtD
Mometasone—Paraesthesia—Bleomycin—skin cancer	0.0009	0.00211	CcSEcCtD
Mometasone—Vomiting—Imiquimod—skin cancer	0.000897	0.0021	CcSEcCtD
Mometasone—Dyspnoea—Bleomycin—skin cancer	0.000894	0.00209	CcSEcCtD
Mometasone—Anorexia—Dactinomycin—skin cancer	0.000891	0.00209	CcSEcCtD
Mometasone—Rash—Imiquimod—skin cancer	0.00089	0.00208	CcSEcCtD
Mometasone—Dermatitis—Imiquimod—skin cancer	0.000889	0.00208	CcSEcCtD
Mometasone—Headache—Imiquimod—skin cancer	0.000884	0.00207	CcSEcCtD
Mometasone—Arthralgia—Temozolomide—skin cancer	0.000882	0.00207	CcSEcCtD
Mometasone—Myalgia—Temozolomide—skin cancer	0.000882	0.00207	CcSEcCtD
Mometasone—Decreased appetite—Bleomycin—skin cancer	0.000871	0.00204	CcSEcCtD
Mometasone—Dry mouth—Temozolomide—skin cancer	0.000863	0.00202	CcSEcCtD
Mometasone—Pain—Bleomycin—skin cancer	0.000857	0.00201	CcSEcCtD
Mometasone—Conjunctivitis—Docetaxel—skin cancer	0.000857	0.00201	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000852	0.002	CcSEcCtD
Mometasone—Anaphylactic shock—Temozolomide—skin cancer	0.000845	0.00198	CcSEcCtD
Mometasone—Infection—Temozolomide—skin cancer	0.00084	0.00197	CcSEcCtD
Mometasone—Nausea—Imiquimod—skin cancer	0.000838	0.00196	CcSEcCtD
Mometasone—Epistaxis—Docetaxel—skin cancer	0.000832	0.00195	CcSEcCtD
Mometasone—Chest pain—Fluorouracil—skin cancer	0.000813	0.0019	CcSEcCtD
Mometasone—Myalgia—Fluorouracil—skin cancer	0.000813	0.0019	CcSEcCtD
Mometasone—Decreased appetite—Dactinomycin—skin cancer	0.000813	0.0019	CcSEcCtD
Mometasone—Fatigue—Dactinomycin—skin cancer	0.000806	0.00189	CcSEcCtD
Mometasone—Anorexia—Temozolomide—skin cancer	0.000806	0.00189	CcSEcCtD
Mometasone—Pain—Dactinomycin—skin cancer	0.000799	0.00187	CcSEcCtD
Mometasone—Rhinitis—Docetaxel—skin cancer	0.000793	0.00186	CcSEcCtD
Mometasone—Body temperature increased—Bleomycin—skin cancer	0.000792	0.00186	CcSEcCtD
Mometasone—Pharyngitis—Docetaxel—skin cancer	0.000785	0.00184	CcSEcCtD
Mometasone—Anaphylactic shock—Fluorouracil—skin cancer	0.000779	0.00183	CcSEcCtD
Mometasone—Infection—Fluorouracil—skin cancer	0.000774	0.00181	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00077	0.0018	CcSEcCtD
Mometasone—Gastrointestinal pain—Dactinomycin—skin cancer	0.000764	0.00179	CcSEcCtD
Mometasone—Paraesthesia—Temozolomide—skin cancer	0.000759	0.00178	CcSEcCtD
Mometasone—Dyspnoea—Temozolomide—skin cancer	0.000754	0.00177	CcSEcCtD
Mometasone—Dyspepsia—Temozolomide—skin cancer	0.000744	0.00174	CcSEcCtD
Mometasone—Anorexia—Fluorouracil—skin cancer	0.000743	0.00174	CcSEcCtD
Mometasone—Abdominal pain—Dactinomycin—skin cancer	0.000739	0.00173	CcSEcCtD
Mometasone—Body temperature increased—Dactinomycin—skin cancer	0.000739	0.00173	CcSEcCtD
Mometasone—Decreased appetite—Temozolomide—skin cancer	0.000735	0.00172	CcSEcCtD
Mometasone—Fatigue—Temozolomide—skin cancer	0.000729	0.00171	CcSEcCtD
Mometasone—Pain—Temozolomide—skin cancer	0.000723	0.00169	CcSEcCtD
Mometasone—Asthenia—Bleomycin—skin cancer	0.000719	0.00168	CcSEcCtD
Mometasone—Immune system disorder—Docetaxel—skin cancer	0.000715	0.00167	CcSEcCtD
Mometasone—Mediastinal disorder—Docetaxel—skin cancer	0.000713	0.00167	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.00071	0.00166	CcSEcCtD
Mometasone—Pruritus—Bleomycin—skin cancer	0.000709	0.00166	CcSEcCtD
Mometasone—Paraesthesia—Fluorouracil—skin cancer	0.000699	0.00164	CcSEcCtD
Mometasone—Dyspnoea—Fluorouracil—skin cancer	0.000695	0.00163	CcSEcCtD
Mometasone—Gastrointestinal pain—Temozolomide—skin cancer	0.000691	0.00162	CcSEcCtD
Mometasone—Triamcinolone—PTGS2—skin cancer	0.000691	0.0711	CrCbGaD
Mometasone—Dyspepsia—Fluorouracil—skin cancer	0.000686	0.00161	CcSEcCtD
Mometasone—Decreased appetite—Fluorouracil—skin cancer	0.000677	0.00159	CcSEcCtD
Mometasone—Asthenia—Dactinomycin—skin cancer	0.000671	0.00157	CcSEcCtD
Mometasone—Abdominal pain—Temozolomide—skin cancer	0.000668	0.00157	CcSEcCtD
Mometasone—Body temperature increased—Temozolomide—skin cancer	0.000668	0.00157	CcSEcCtD
Mometasone—Back pain—Docetaxel—skin cancer	0.000666	0.00156	CcSEcCtD
Mometasone—Pain—Fluorouracil—skin cancer	0.000666	0.00156	CcSEcCtD
Mometasone—Diarrhoea—Dactinomycin—skin cancer	0.00064	0.0015	CcSEcCtD
Mometasone—Vomiting—Bleomycin—skin cancer	0.000637	0.00149	CcSEcCtD
Mometasone—Rash—Bleomycin—skin cancer	0.000632	0.00148	CcSEcCtD
Mometasone—Dermatitis—Bleomycin—skin cancer	0.000631	0.00148	CcSEcCtD
Mometasone—Body temperature increased—Fluorouracil—skin cancer	0.000616	0.00144	CcSEcCtD
Mometasone—Asthenia—Temozolomide—skin cancer	0.000607	0.00142	CcSEcCtD
Mometasone—Cough—Docetaxel—skin cancer	0.000601	0.00141	CcSEcCtD
Mometasone—Pruritus—Temozolomide—skin cancer	0.000598	0.0014	CcSEcCtD
Mometasone—Nausea—Bleomycin—skin cancer	0.000595	0.00139	CcSEcCtD
Mometasone—Vomiting—Dactinomycin—skin cancer	0.000594	0.00139	CcSEcCtD
Mometasone—Rash—Dactinomycin—skin cancer	0.000589	0.00138	CcSEcCtD
Mometasone—Arthralgia—Docetaxel—skin cancer	0.000587	0.00137	CcSEcCtD
Mometasone—Chest pain—Docetaxel—skin cancer	0.000587	0.00137	CcSEcCtD
Mometasone—Myalgia—Docetaxel—skin cancer	0.000587	0.00137	CcSEcCtD
Mometasone—Diarrhoea—Temozolomide—skin cancer	0.000578	0.00136	CcSEcCtD
Mometasone—Dry mouth—Docetaxel—skin cancer	0.000574	0.00134	CcSEcCtD
Mometasone—Betamethasone—PTGS2—skin cancer	0.000566	0.0582	CrCbGaD
Mometasone—Anaphylactic shock—Docetaxel—skin cancer	0.000562	0.00132	CcSEcCtD
Mometasone—Infection—Docetaxel—skin cancer	0.000559	0.00131	CcSEcCtD
Mometasone—Nausea—Dactinomycin—skin cancer	0.000555	0.0013	CcSEcCtD
Mometasone—Pruritus—Fluorouracil—skin cancer	0.000551	0.00129	CcSEcCtD
Mometasone—Vomiting—Temozolomide—skin cancer	0.000538	0.00126	CcSEcCtD
Mometasone—Anorexia—Docetaxel—skin cancer	0.000536	0.00126	CcSEcCtD
Mometasone—Rash—Temozolomide—skin cancer	0.000533	0.00125	CcSEcCtD
Mometasone—Diarrhoea—Fluorouracil—skin cancer	0.000533	0.00125	CcSEcCtD
Mometasone—Dermatitis—Temozolomide—skin cancer	0.000533	0.00125	CcSEcCtD
Mometasone—Headache—Temozolomide—skin cancer	0.00053	0.00124	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000512	0.0012	CcSEcCtD
Mometasone—Paraesthesia—Docetaxel—skin cancer	0.000505	0.00118	CcSEcCtD
Mometasone—Nausea—Temozolomide—skin cancer	0.000502	0.00118	CcSEcCtD
Mometasone—Dyspnoea—Docetaxel—skin cancer	0.000501	0.00117	CcSEcCtD
Mometasone—Vomiting—Fluorouracil—skin cancer	0.000495	0.00116	CcSEcCtD
Mometasone—Dyspepsia—Docetaxel—skin cancer	0.000495	0.00116	CcSEcCtD
Mometasone—Rash—Fluorouracil—skin cancer	0.000491	0.00115	CcSEcCtD
Mometasone—Dermatitis—Fluorouracil—skin cancer	0.000491	0.00115	CcSEcCtD
Mometasone—Decreased appetite—Docetaxel—skin cancer	0.000489	0.00115	CcSEcCtD
Mometasone—Headache—Fluorouracil—skin cancer	0.000488	0.00114	CcSEcCtD
Mometasone—Fatigue—Docetaxel—skin cancer	0.000485	0.00114	CcSEcCtD
Mometasone—Pain—Docetaxel—skin cancer	0.000481	0.00113	CcSEcCtD
Mometasone—Nausea—Fluorouracil—skin cancer	0.000463	0.00108	CcSEcCtD
Mometasone—Gastrointestinal pain—Docetaxel—skin cancer	0.00046	0.00108	CcSEcCtD
Mometasone—Body temperature increased—Docetaxel—skin cancer	0.000444	0.00104	CcSEcCtD
Mometasone—Abdominal pain—Docetaxel—skin cancer	0.000444	0.00104	CcSEcCtD
Mometasone—Asthenia—Docetaxel—skin cancer	0.000403	0.000945	CcSEcCtD
Mometasone—Pruritus—Docetaxel—skin cancer	0.000398	0.000932	CcSEcCtD
Mometasone—Diarrhoea—Docetaxel—skin cancer	0.000385	0.000901	CcSEcCtD
Mometasone—Vomiting—Docetaxel—skin cancer	0.000357	0.000838	CcSEcCtD
Mometasone—Rash—Docetaxel—skin cancer	0.000355	0.000831	CcSEcCtD
Mometasone—Dermatitis—Docetaxel—skin cancer	0.000354	0.00083	CcSEcCtD
Mometasone—Headache—Docetaxel—skin cancer	0.000352	0.000825	CcSEcCtD
Mometasone—Nausea—Docetaxel—skin cancer	0.000334	0.000783	CcSEcCtD
Mometasone—Dexamethasone—PTGS2—skin cancer	0.000329	0.0339	CrCbGaD
